Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). (Q36884852)
Jump to navigation
Jump to search
scientific article published on 7 March 2016
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). |
scientific article published on 7 March 2016 |
|
Statements
1 reference
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). (English)
1 reference
Nan Zhou
1 reference
Ting Pan
1 reference
Junsong Zhang
1 reference
Qianwen Li
1 reference
Xue Zhang
1 reference
Chuan Bai
1 reference
Feng Huang
1 reference
Tao Peng
1 reference
Jianhua Zhang
1 reference
Chao Liu
1 reference
Liang Tao
1 reference
Hui Zhang
1 reference
7 March 2016
1 reference
1 reference
9218-9232
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference